These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32822128)

  • 1. Anxiety and depression associated with a positive prostate biopsy result: A comparative, prospective cohort study.
    Sefik E; Gunlusoy B; Eker A; Celik S; Ceylan Y; Koskderelioglu A; Basmaci I; Degirmenci T
    Int Braz J Urol; 2020; 46(6):993-1005. PubMed ID: 32822128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
    Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alpha blocker treatment prior to prostate biopsy on voiding functions, pain scores and health-related quality-of-life outcomes: A prospective randomized trial.
    Sefik E; Eker A; Gunlusoy B; Celik S; Bozkurt IH; Basmaci I; Polat S; Degirmenci T; Ceylan Y
    Prog Urol; 2020 Mar; 30(4):198-204. PubMed ID: 31983605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May ultrasound probe size influence pain perception of needle piercing during transrectal prostate biopsy? A prospective evaluation.
    Fabiani A; Servi L; Filosa A; Fioretti F; Maurelli V; Tombolini F; Tallè M; Mammana G
    Arch Ital Urol Androl; 2016 Oct; 88(3):223-227. PubMed ID: 27711100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.
    Wade J; Rosario DJ; Howson J; Avery KN; Salter CE; Goodwin ML; Blazeby JM; Lane JA; Metcalfe C; Neal DE; Hamdy FC; Donovan JL
    BMC Health Serv Res; 2015 Feb; 15():80. PubMed ID: 25889315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of health literacy on patient compliance in patients to whom prostate biopsies were recommended.
    Gercek O; Demirbas A; Topal K; Eren B; Yazar VM
    BMC Urol; 2024 Aug; 24(1):172. PubMed ID: 39134976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-guided biopsies may improve diagnosis in biopsy-naive men with suspicion of prostate cancer.
    Winther MD; Balslev I; Boesen L; Logager V; Noergaard N; Thestrup KD; Thomsen HS
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-parametric magnetic resonance imaging monitoring patients in active surveillance for prostate cancer: a prospective cohort study.
    Elkjær MC; Andersen MH; Høyer S; Pedersen BG; Borre M
    Scand J Urol; 2018 Feb; 52(1):8-13. PubMed ID: 29212392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
    Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG
    Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of prostate biopsy on erectile and ejaculatory function: A prospective study.
    Morelli M; Sampogna G; Molteni S; Sciorio C; Lorusso V; Romano L; La Rocca R; Capece M; Zimarra A; Napolitano L; Verze P; Spirito L
    Arch Ital Urol Androl; 2022 Dec; 94(4):420-423. PubMed ID: 36576472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research.
    Altok M; Kim B; Patel BB; Shih YT; Ward JF; McRae SE; Chapin BF; Pisters LL; Pettaway CA; Kim J; Demirel HC; Davis JW
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):524-532. PubMed ID: 29988098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
    Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
    Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
    Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
    Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.